{{Drugbox
| IUPAC_name               = 4,4-diphenyl-6-(1-piperidinyl)-3-hexanone
| image                    = Norpipanone2DCSD.svg
| CAS_number               = 561-48-8
| CAS_supplemental         = 
| ATC_prefix               = None
| ATC_suffix               = 
| PubChem                  = 22391
| ChemSpiderID             = 21015
| C=23 | H=29 | N=1 | O=1
| molecular_weight         = 335.483 g/mol
| smiles                   = O=C(C(c1ccccc1)(c2ccccc2)CCN3CCCCC3)CC
| synonyms                 = Herchst 10495, NIH-7557
| StdInChI                 = 1S/C23H29NO/c1-2-22(25)23(20-12-6-3-7-13-20,21-14-8-4-9-15-21)16-19-24-17-10-5-11-18-24/h3-4,6-9,12-15H,2,5,10-11,16-19H2,1H3
| StdInChIKey              = WCDSHELZWCOTMI-UHFFFAOYSA-N
| bioavailability          = 
| protein_bound            = 
| metabolism               = 
| elimination_half-life    = 
| excretion                = 
| pregnancy_category       = 
| legal_AU                 = S9
| legal_CA = Schedule I
| legal_DE = Anlage I
| legal_US = Schedule I
| routes_of_administration = 
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 127X8DJ74M
}}

'''Norpipanone''' ([[International Nonproprietary Name|INN]], [[British Approved Name|BAN]]; '''Hexalgon''') is an [[opioid]] [[analgesic]] related to [[methadone]] which was developed in [[Germany]] and distributed in [[Hungary]], [[Argentina]], and other countries.<ref name="Buckingham1995">{{cite book | author = John B Buckingham | title = Dictionary of Organic Compounds | url = https://books.google.com/books?id=C3Uo1co4Wv0C&pg=PA2883 | accessdate = 11 May 2012 | date = December 1995 | publisher = CRC Press | isbn = 978-0-412-54090-5 | page = 2883}}</ref><ref name="Patterson2002">{{cite book | author = David S. Patterson | title = Foreign Relations of the United States, 1961-1963, Volume XXV: Organization of Foreign Policy; Information Policy; United Nations; Scientific Matters | url = https://books.google.com/books?id=wn4hSwZRaXsC&pg=PA766 | accessdate = 11 May 2012 | date = 12 March 2002 | publisher = Government Printing Office | isbn = 978-0-16-050885-1 | pages = 766–767}}</ref> It had originally not been under [[drug prohibition law|international control]] but upon observation of [[case report]]s of [[addiction]] it was reviewed and shortly thereafter became a [[controlled substance]].<ref name="Buckingham1995" /><ref name="Patterson2002" /> In the United States, it is a Schedule I controlled substance (ACSCN 9636, zero annual manufacturing quota as of 2014).  The salts in use are the hydrobromide (free base conversion ratio 0.806) and hydrochloride (0.902).

==Synthesis==
[[File:Norpipanone synthesis.png|thumb|center|700px|Norpipanone synthesis:<ref>{{cite journal | doi= 10.1039/JR9490000500 | title= 113. Analgesics. Part I. Esters and ketones derived from α-amino-ω-cyano-ωωdiarylalkanes| journal= [[Journal of the Chemical Society]] (Resumed) | publisher= [[Chemical Society]]| date= 1949 | pages= 500 | first1= D. J. | last1= Duprè| first2= J.| last2= Elks| first3= B. A. | last3= Hems| first4=K. N.| last4= Speyer | first5= R. M.| last5= Evans  }}</ref><ref>{{Cite journal | doi = 10.1002/jlac.19495610107| title = Über eine neue Klasse von spasmolytisch und analgetisch wirkenden Verbindungen, I| journal = Justus Liebigs Annalen der Chemie| volume = 561| pages = 52| year = 1949| last1 = Bockmühl | first1 = M. | last2 = Ehrhart | first2 = G. }}</ref>]]

== See also ==
* [[Dipipanone]]
* [[Normethadone]]
* [[Valeronitrile]]

== References ==
{{Reflist|2}}


{{Analgesics}}
{{Opioidergics}}

[[Category:Analgesics]]
[[Category:Ketones]]
[[Category:Opioids]]
[[Category:Piperidines]]


{{analgesic-stub}}